首页> 美国卫生研究院文献>British Journal of Clinical Pharmacology >Relevance of selectivity and non-selectivity in beta-adrenoceptor blocking drugs.
【2h】

Relevance of selectivity and non-selectivity in beta-adrenoceptor blocking drugs.

机译:β-肾上腺素受体阻断药中选择性和非选择性的相关性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1 The heart rate responses to increasing doses of isoprenaline (n = 6) (during infusion with atropine 0.5 mg/min i.v.) and noradrenaline (n = 5), (during infusion with phentolamine 160 mg/h i.v.) were recorded before and after the intravenous administration of propranolol (15 mg) or metoprolol (15 mg). 2 In the doses used, metoprolol was less potent than propranolol in antagonizing isoprenaline-induced tachycardia, during atropine infusion. 3 In volunteers treated with phentolamine both metoprolol and propranolol produced similar inhibition of noradrenaline-induced tachycardia, indicating comparable beta 1-adrenoceptor blockade in the doses used. 4 The fact that the shift of the dose-response curve of isoprenaline-induced tachycardia was smaller after metoprolol than after propranolol supports the hypothesis that beta 2-adrenoceptors are present in the heart.
机译:1记录了异丙肾上腺素(n = 6)(在输注阿托品0.5 mg / min iv期间)和去甲肾上腺素(n = 5)(在苯妥拉明160 mg / h iv期间)剂量增加时的心率响应普萘洛尔(15 mg)或美托洛尔(15 mg)的静脉内给药。 2在阿托品输注期间,美托洛尔在拮抗异丙肾上腺素引起的心动过速方面的效用低于普萘洛尔。 3在用酚妥拉明治疗的志愿者中,美托洛尔和普萘洛尔均产生相似的抑制去甲肾上腺素引起的心动过速的抑制作用,表明在所用剂量中可比的β1-肾上腺素受体阻滞剂。 [4]美托洛尔治疗后异丙肾上腺素诱发的心动过速的剂量反应曲线的变化比普萘洛尔治疗后的剂量响应曲线的变化小,这一事实支持以下假设:心脏中存在β2肾上腺素能受体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号